OBIO TECHNOLOGY (SHANGHAI) CORP LTD revenue breakdown overview

OBIO TECHNOLOGY (SHANGHAI) CORP LTD revenue for the last year amounted to 204.81 M CNY, the most of which — 106.99 M CNY — came from its highest performing source at the moment, Gene Therapy Contract Development and Manufacturing Organization, the year earlier bringing 216.77 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought OBIO TECHNOLOGY (SHANGHAI) CORP LTD 204.49 M CNY, and the year before that — 290.22 M CNY.